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Copyright © 200? JCBN Summary It has been reported that Ocimum sanctum L. (OS) leaves decrease serum lipid
profile in normal and diabetic animals. No experimental evidences support the anti-
hyperlipidemic and antioxidative actions against hypercholesterolemia. Moreover the identity
of the specific chemical ingredients in OS leaves responsible for these pharmacological effects
are unknown. Since OS leaves are rich in essential oil (EO). Therefore the present study was
conducted to investigate the anti-hyperlipidemic and antioxidative activities of EO extracted
from OS leaves in rats fed with high cholesterol (HC) diet. EO was extracted by the
hydrodistillation method and the chemical constituents were then identified by Gas Chroma-
tography-Mass Spectrometry. The experiment was performed in Male Wistar rats fed with
2.5 g%(w/w) of cholesterol diet for seven weeks. During the last 3 weeks, rats were daily fed
with EO. The results showed that phenyl propanoid compounds including eugenol and methyl
eugenol were the major constituents of EO. EO suppressed the high serum lipid profile and
atherogenic index as well as serum lactate dehydrogenase and creatine kinase MB subunit
without significant effect on high serum levels of aspartate aminotransferase, alanine amino-
transferase and alkaline phosphatase in rats fed with HC diet. In addition, EO was found to
decrease the high levels of thiobarbituric acid reactive substances (TBARS), glutathione
peroxidase (GPx) and superoxide dismutase (SOD) without impacting catalase (CAT) in the
cardiac tissue while in the liver, it decreased high level of TBARS without significantly
effecting GPx, SOD and CAT. Histopathological results confirmed that EO preserved the
myocardial tissue. It can be concluded that EO extracted from OS leaves has lipid-lowering
and antioxidative effects that protect the heart against hypercholesterolemia. Eugenol that is
contained in EO likely contribute to these pharmacological effects.
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Introduction
Hypercholesterolemia is widely known to be the major
risk factor for the development of cardiovascular diseases
[1,  2]. The modern lifestyle with high fat diet and less
physical activity significantly contribute to hypercholester-
olemia and cardiovascular diseases [1, 3]. Oxidative stress
induced by reactive oxygen species (ROS) also plays an
important role in the etiology of several diseases including
atherosclerosis and coronary heart disease [4,  5]. Hyper-
cholesterolemia has been found to induce oxidative stress in
various organs such as the liver, heart and kidney [6]. It has
been shown that majority of the plants with antioxidant
products have a potential role in protecting people from
several illnesses such as cardiovascular diseases [5,  7].
There are several kinds of medicinal plants with hypo-
lipidemic and antioxidative activities. One of those plants,
Ocimum sanctum L. (OS), commonly used as a vegetable,
has shown its potential to be therapeutic in averting several
diseases in various Asian countries including India and
Thailand. OS is a small herb, native to tropical and sub-
tropical regions. It is known as Tulsi or Holy Basil in
English and India. It has been shown that 2% of dried OS
leaf powder supplemented in the diet can lower serum lipid
profile and partially protect the liver in diabetic rats [8]. It
has also been shown that OS leaf extracts can protect the
liver from heavy metals [9] and prevent isoproterenal-
induced myocardial necrosis in rats [10]. Even though OS
leaves have hypolidemic and organ protective effects against
various stress conditions, yet there are no research studies
providing evidences for its anti-hyperlipidemic and anti-
oxidative effects to protect the primary risk organs against
hypercholesterolemia. Moreover, the chemical constituents
in OS leaves contributing to these actions have not yet been
identified. It is known that OS leaves are riched in essential
oils (EO), and the primary risk organs of hypercholester-
olemia are the liver and heart. Therefore, the present study
was conducted to investigate anti-hyperlipidemic and anti-
oxidative actions of EO extracted from OS leaves to protect
the liver and heart in rats fed with high cholesterol diet. The
chemical composition of EO was also identified.
Materials and Methods
Extraction of essential oils from Ocimum sanctum L. leaves
OS fresh leaves were obtained from the Institute of
Thai Traditional Medicine, the Ministry of Public Health
of Thailand. Fresh leaves of OS were washed in tap water
and then cut into small pieces. The EO from OS leaves was
extracted by the hydrodistillation method as described by
the Association of Official Analytical Chemists (method
962.17, AOAC, 1990). After the extraction process, the
percent yield of EO was 1.82 ml/100 g of fresh OS leaves.
The EO was collected and stored at 4°C before analyzing
its chemical constituents by Gas Chromatography-Mass
Spectrometry (GC-MS).
Identification of volatile constituents using GC-MS
The EO was diluted to 1:100 in methanol before being
injected into the GC-MS system. The Varian Saturn III
instrument was used for Gas Chromatography-Mass Spectro-
metry analysis. The column was a DB-5 fused silica capil-
lary column 30 m (0.25 mm i.d., 0.25 µM film thickness).
Oven temperature programming was 50–240°C with an
increase of 3°C/min. Injector and detector temperatures
were 240°C. The volume of the injector was 1 µl; the split
ratio was 100:1, the accelerating voltage was 1700 volts, and
the carrier gas was helium. Identification was based on
sample retention time data and comparison with authentic
standards, electron impact-mass spectra (EI-MS) data and
computer matching using NIST library. (NIST = NIST.
Mass Spectral Library, The National Institute of Standards
and Technology, UK, 1998).
Animal preparation
Male Wistar rats weighing between 90–120 g were pur-
chased from the Animal Center, Salaya Campus, Mahidol
University, Thailand. The rats were cared for in accordance
with the principles and guidelines of the Institutional Animal
Ethics Committee of Rangsit University, which is under The
National Council of Thailand for Animal Care. The rats
were housed in a 12-h light–dark cycle room with controlled
temperature at 25 ± 2°C and fed with standard rat food and
tap water ad libitum. Hypercholesterolemia was induced by
adding 2.5 g% (w/w) cholesterol powder and 6% (v/w) palm
oil to the food. Three groups of seven rats each were fed on
the following diet for 7 weeks: group I, normal diet for a
control; group II, a high cholesterol (HC) diet; and group III,
a HC diet and EO was intragastrically administered daily for
the last three weeks.
From our previous study, supplementation of 2% dried OS
leaf powder in diet for three weeks showed lipid-lowering
effect and partially protected the liver in diabetic rats [8].
The percent yield of EO was 1.82 ml/100 g of fresh OS
leaves which was equivalent to 1.82 ml/10.13 g dried OS
leaf powder. The average amount of dried OS leaf powder
consumption by each rat was 4.45 g/kgbw/day. Therefore
the daily dose of EO administered in this study was calcu-
lated based on these values and was approximately 80 µl/
kgbw/day. EO was dissolved in liquid paraffin emulsion at
the concentration of 30 µl/ml. During the last three weeks of
the experiment, 0.8 ml of liquid paraffin emulsion was daily
fed to group I and II whereas group III was daily fed with
EO. To improve absorption, food was withheld for two hours
before EO or liquid paraffin emulsion was administered.
Body weight and food consumption were recorded weeklyT. Suanarunsawat et al.
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throughout seven weeks.
At the end of the study, the rats were fasted overnight
and were anesthetized by intraperitoneal injection with
zolitil (40 mg/kgbw) plus xylazine (3 mg/kgbw). Blood was
collected from the abdominal vein to determine the serum
lipid profile: total cholesterol, triglyceride, low density
lipoprotein cholesterol (LDL-C), and high density lipo-
protein cholesterol (HDL-C). The atherogenic index (AI)
was later calculated as the ratio of TC-HDL-C/HDL-C.
Evaluation of liver and cardiac function
Liver function was evaluated by assessing for serum
alanine aminotransferase (ALT), aspartate aminotransferase
(AST) and alkaline phosphatase (AP) levels. Cardiac
function was also assessed by measuring the serum lactate
dehydrogenase (LDH) and creatine kinase MB subunit (CK–
MB) levels.
Assessment of lipid peroxide and the activity of antioxidant
enzymes in both the liver and heart
At the end of the study, rat was anesthetized and the
jugular vein was canulated to perfuse ice cold normal saline
to remove red blood cells. Immediately after perfusion, both
the liver and heart were isolated, cleaned and weighed. Both
organs were kept at −80°C until further analysis was done.
Assessment of tissue lipid peroxide content
Lipid peroxides in both liver and heart were assessed
with thiobarbituric acid reactive substances (TBARS) as
described previously [11]. TBARS was expressed in nmole
of malondialdehyde (MDA)/mg protein using 1,1,3,3-
tetraethoxy propane as a standard. Tissue protein levels
were determined with the Lowry’s method [12].
Assessment of the activity of tissue antioxidant enzymes
Antioxidant enzymes such as glutathione peroxidase
(GPx), catalase (CAT) and superoxide dismutase (SOD)
were determined in the liver and heart. Liver and cardiac
tissue homogenates were prepared by homogenizing the
tissues in a 0.1 M phosphate buffer pH 7.4. The homogenate
was then centrifuged at 3,000 rpm, 4°C for 10 min. Superna-
tant was collected and centrifuged again at 7,800 g, 4°C for
30 min. The supernatant fraction was collected and further
centrifuged at 136,000 g, 4°C for 60 min. The final superna-
tant was then analyzed for estimation of GPx, CAT and SOD
using the procedures described by Tapple [13], Luck [14]
and Winterbourn et al. [15] respectively.
Evaluation of the liver and cardiac morphology
After the liver and heart were isolated, cleaned and dried,
then fixed in a buffer solution of 10% neutral buffered
formalin. For histopathological observations, longitudinal
sections of myocardial tissue were cut at the macroscopic
lesions. As for the liver, sections were cut through the
macroscopic lesions including capsules. The sections were
further cut to 5 microns thickness and stained with haema-
toxylin and eosin (H&E) [16].
Biochemical assay
Serum total cholesterol, triglyceride and HDL-C were
assayed by using an enzymatic kit (Gesellschaft Für
Biochemica und Diagnostica GmbH, Germany). LDL-C
was calculated by using the equation: LDL-C = TC–(HDL-
C)–(triglyceride/5). Serums levels for AST, ALT, AP, LDH
and CK–MB were measured by using an enzymatic kit
(Randox Laboratories, UK).
Statistical analysis
All values are presented as mean ± SEM. The results
were analyzed by ANOVA. The Ducan multiple rank test
was performed to determine statistical significance among
groups by using SPSS software version 11.5. Significant
difference was accepted at the p<0.05.
Results
Fig. 1 shows GC of the EO extracted from OS leaves.
The chemical constituents of EO are displayed in Table 1.
The EO is predominantly composed mainly of phenyl-
propanoids (65.31%) eugenol and methyl eugenol. 9-epi
(E)-Caryophyllene which is sesquiterpene compound, was
found 23.68% in EO. Small amounts of monoterpene and
oxygenated monoterpene were also found in EO.
Body weight gain and food consumption were not signifi-
cantly different in all groups of rats (data was not shown).
Seven weeks of HC diet feeding raised serum total choles-
terol, triglyceride, LDL-C and AI whereas HDL-C was
slightly decreased (Table 2). EO treatment attenuated the
high serum levels of cholesterol, LDL-C, AI, and normal-
ized triglyceride and HDL-C. The HC diet significantly
raised serums ALT, AST, AP, LDH and CK-MB (Table 3).
In HC rats treated with EO, CK-MB and LDH levels were
returned to normal levels, although ALT, AST and AP levels
remained elevated.
Levels of hepatic lipid peroxides increased whereas GPx,
CAT and SOD activities were decreased in HC rats
(Table 4). EO depressed high level of liver TBARS without
significantly effecting GPx, CAT and SOD activities. For
cardiac tissue, TBARS was significantly increased while
the activities of GPx and SOD were reduced in HC rats. In
contrast, the rats treated with EO showed a huge reduction in
cardiac TBARS and an increase in GPx and SOD activities.
The cardiac CAT activity in HC rats treated with EO was
increased to the similar level of normal rat but the level was
not statistically significant difference from HC rats.
From the histopathological analysis, the normal hepato-Antioxidant Activity and Lipid-Lowering Effect of Essential Oils
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cyte had the round nucleus centrally and homogeneous
cytoplasm (Fig. 2A). There are flat endothelial cells around
central vein and sinusoid. The hepatic cord arrangement as a
regular ray pattern was also seen in normal hepatocyte.
The hepatocytes from HC rats showed diffused vacuolar
degeneration and necrosis (loss of nucleus) which indicated
that the cells were severely deteriorated (Fig. 2B). Endo-
thelial lining of the central vein exhibited more cell injury
with an increased accumulation of fat vacuoles in the
hepatocytes. Hepatic cells did not recover or improve
with EO usage even though there were fewer endothelium
injuries and vacuole buildup (Fig. 2C). Myocardiocyte of
Fig. 1. Chromatogram of the essential oils extracted from OS leaves
Table 1. Chemical composition of essential oils extracted from Ocimum sanctum L. leaves by hydrodistillation method
t=t r a c e
Number 
of peak
Chemical compounds and 
structures
Retention time 
(min)
% Area Molecular 
formula
Molar mass 
(g/mol)
mm Monoterpene
1 α-thujene 5.48 0.19 C10 H16 136.23
2 camphene 5.62 0.21 C10 H16 136.24
3 sabinene 6.33 t C10 H16 136.23
4 β-pinene 6.39 0.13 C10 H16 136.24
5 limonene 7.96 0.08 C10 H16 136.24
Oxygenated monoterpene
6 1,8-cineole 8.11 0.06 C10 H18 O 154.249
7 linalool 10.59 0.3 C10 H18 O 154.25
8 borneol 13.59 0.54 C10 H18 O 154.249
Sesquiterpene
10 β-elemene 23.07 2.64 C15 H24 204.35
12 9-epi (E)-caryophyllene 25.41 23.68 C15 H24 204.36
13 α-humulene 25.8 1.5 C15 H24 204.36
14 γ-muurolene 26.39 0.4 C15 H24 204.35
15 β-selinene 26.78 0.11 C15 H24 204.35
16 α-selinene 27.16 0.11 C15 H24 204.35
17 α-bulnesene 27.48 4.6 C15 H24 204.35
18 δ-cadinene 29.01 0.1 C15 H24 204.35
Phenyl propanoid
9 eugenol 21.26 18.25 C10 H12 O2 164.2
11 methyl eugenol 23.61 47.06 C11 H14 O2 178.23T. Suanarunsawat et al.
J. Clin. Biochem. Nutr.
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Table 2. Changes of liver weight, heart weight and serum lipid profile in normal rats, HC rats and HC rats
treated with essential oils of Ocimum sanctum L. leaves
Values are expressed as mean ± SEM of seven rats per group. Values with different superscripts in the same row
are significantly different at p<0.05.
group
Normal HC HC + EO
Organ weight (g/kgbw)
Liver 32.5 ± 0.6a 62.2 ± 1.5b 65.8 ± 1.5b
heart 3.53 ± 0.1 3.33 ± 0.09 3.30 ± 0.08
Serum lipid (mg/dl)
Total cholesterol 38 ± 2a 133 ± 5b 112 ± 3c
Triglyceride 25 ± 1a 50 ± 7b 26 ± 3a
HDL-C 20 ± 0ab 17 ± 1a 22 ± 2b
LDL-C 13 ± 1a 105 ± 6b 85 ± 2c
AI 0.9 ± 0.1a 6.9 ± 0.8b 4.4 ± 0.4c
Table 3. Changes of serum alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline
phosphatase (AP), lactate dehydrogenase (LDH) and creatine kinase MB subunit (CK–MB) in
normal rats, HC rats and HC rats treated with essential oils of Ocimum sanctum L. leaves
Values are expressed as mean ± SEM of seven rats per group. Values with different superscripts in the
same row are significantly different at p<0.05.
group
Normal HC HC + EO
ALT (U/L) 25 ± 1a 118 ± 17b 119 ± 36b
AST (U/L) 67 ± 3a 166 ± 14b 193 ± 22b
AP (U/L) 117 ± 8a 204 ± 8b 213 ± 11b
LDH (U/L) 530 ± 78a 825 ± 86b 487 ± 51a
CK-MB(U/L) 499 ± 56a 685 ± 35b 514 ± 40a
Table 4. Effect of essential oils extracted from Ocimum sanctum L. leaves on lipid peroxide and antioxidant enzymes
activity in liver and heart in HC rats.
Values are expressed as mean ± SEM of seven rats per group. TBARS, thiobarbituric acid reactive substances; GPx,
glutathione peroxidase; CAT, catalase; SOD, superoxide dismutase. Values with different superscripts in the same row are
significantly different at p<0.05.
group
Normal HC HC + EO
Liver
TBARS (nmole MDA/mg protein) 0.88 ± 0.06a 1.38 ± 0.04b 0.67 ± 0.06c
GPx (μmole/min/mg protein) 1.3 ± 0.06a 0.97 ± 0.02b 1.07 ± 0.09b
CAT (μmole/min/mg protein) 360 ± 16.6a 275 ± 18b 242 ± 15b
SOD (unit/mg protein) 103 ± 13.9a 40.1 ± 3.29b 47.1 ± 5.17b
Heart
TBARS (nmole MDA/mg protein) 1.0 ± 0.05a 1.83 ± 0.05b 0.35 ± 0.03c
GPx (μmole /mg protein) 0.28 ± 0.02a 0.20 ± 0.02b 0.27 ± 0.03a
CAT (μmole/min/mg protein) 6.95 ± 0.38a 5.82 ± 0.31a 6.80 ± 0.49a
SOD (unit/mg protein) 25.3 ± 2.1a 14.3 ± 1.2b 61.4 ± 5.4cAntioxidant Activity and Lipid-Lowering Effect of Essential Oils
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normal rats had oval-elongate nucleus centrally and homo-
geneous cytoplasm (Fig. 3A). The HC rats exhibited a
moderate dilation and thinning of the right ventricle wall with
mild cardiac hypertrophy of the left ventricle. Furthermore,
multi-focal vacuolar degeneration and necrosis or apoptosis
were seen in the myocardial cells (Fig. 3B). In contrast,
myocardial cell of HC rat treated with EO revealed normal
general appearance (Fig. 3C).
Discussion
Cardiovascular diseases, particularly coronary artery
disease (CAD), have become a growing problem, and is the
primary cause of mortality in both western countries and
most parts of Asia [2, 17]. Several lines of evidences show
that the improvement and incidence of CAD is associated
with lowering hypercholesterolemia [1, 18]. To treat hyper-
cholesterolemia, extensive interventions are recommended,
including diet control, exercise and the use of hypocholester-
olemic drugs. However some patients cannot tolerate the
adverse effects from these drugs, such as liver damage [19]
which indicates the need to find other safer yet efficacious
alternatives. Many epidemiological studies have indicated
that diet with high plant content can protect people from
various serious diseases such as cancer, diabetes mellitus
and cardiovascular disease [7, 20]. The present study shows
that, as expected, seven weeks of HC diet feeding raised
serum lipid profile and AI. EO treatment attenuated the high
serum lipid profile and AI. This implies that EO contained
in the OS leaves contributes to the anti-hyperlipidemic
Fig. 2. Histopathological appearance of liver (H&E ×400). Normal hepatocyte had the round nucleus centrally (arrows), the flat
endothelial cells (arrow-heads) are around the central vein (CV) (A). Diffuse vacuolar degeneration and necrosis of hepatocytes
(arrows) and markedly focal fibrosis (arrow-head) were shown in HC rat (B). Hepatic cells of HC rat treated with EO (C),
periacinar vacuolar cytoplasmic degeneration (arrows), 1–2 hepatocyte rows around central vein demonstrated hepatic cell
degeneration and necrosis (arrow-head). Less injury of endothelium and less fat vacuole comparing to HC rat. HC, high
cholesterol; EO, essential oil.
Fig. 3. Histopathological appearance of myocardial cells (H&E ×400). Oval-elongate nucleus centrally and homogeneous cytoplasm
(arrows) in normal myocardial cell (A). Multi-focal vacuolar degeneration and necrosis of myocardial cells (arrow-heads) in
HC rat (B). Apoptosis of myocardiocytes were also observed (arrow in B). Normal general appearance of myocardial cells in
HC rat treated with EO (C). HC, high cholesterol; EO, essential oil.T. Suanarunsawat et al.
J. Clin. Biochem. Nutr.
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action of OS leaves, and could be effective to alleviate
atherosclerosis which then eventually prevents the occur-
rence of CAD. The anti-hyperlipidemic activity of EO may
be due to the suppression of liver lipid synthesis [21].
It is widely known that both the liver and heart are at
risk in patients with hypercholesterolemia. Our results
showed that HC diet markedly suppressed hepatic and
cardiac functions as expressed by an augmentation of serum
AST, ALT, AP, LDH and CK-MB (Table 3). Hepatic and
cardiac lipid peroxidation as observed by the TBARS in
both organs, were also increased in HC rats. Moreover,
antioxidant enzyme activities in both organs were depressed.
These results indicate that seven weeks of HC diet feeding
induces oxidative stress to injure the liver and heart. Though
OS leaves have been reported to protect both organs in
various stress conditions as mentioned earlier, no experi-
mental study was carried out to clarify its antioxidative
action to protect both the liver and heart against hyper-
cholesterolemia. EO treatment was able to normalize the
high serum levels of LDH and CK-MB. Likewise, cardiac
lipid peroxidation was markedly suppressed whereas the
activity of cardiac antioxidant enzymes increased in rats
treated with EO. This indicates that EO contained in the OS
leaves had free radical scavenging activity which probably
contributed to the cardioprotective effect against hyper-
cholesterolemia.
As for the results from the liver, EO suppressed high
levels of liver lipid peroxidation and slightly improved
hepatocyte degeneration. However its effect was not
powerful enough to protect the liver function as shown by
the unchanged serum levels of ALT, AST and AP which
remained high. This finding was quite difference from our
previous study which showed that OS dried leaf powder
supplemented in normal diet partially protected the liver in
diabetic rats [8]. The reason may be that OS leaf powder
contains several other kinds of chemical ingredients such as
ursolic acid, apigenin, orientin, and linoleic acid. The
hepatoprotective activity of OS leaves might be caused by
other chemicals. The present study clearly shows that EO
extracted from OS leaves may of the therapeutic importance
not only as an anti-hyperlipidemic agent to prevent athero-
sclerosis but also as an cytoprotective agent to protect
cardiac injury against hypercholesterolemia. However, the
other chemical ingredients in OS leaves might participate in
lipid-lowering and cardiac protective actions of OS leaves,
and hence should not be excluded.
Among the chemical constituents contained in EO,
eugenol, a phenolic compound, may be an active ingredient
contributing for EO’s actions. This is supported by its action
to lower high serum lipid profile in hyperlipidemic mice
[22]. Moreover, eugenol has been shown to express anti-
oxidant activity as detected by the DPPH assay [23].
Eugenol also attenuated isoproterenol-induced cardiac
apoptosis [24]. It has been known that oxidation of low-
density lipoprotein (LDL) is an important risk factor for
atherosclerosis development [25]. LDL oxidation was in-
creased in rabbit fed with HC diet for 8 weeks [26]. Eugenol
has been found to act as an antioxidant to inhibit LDL oxida-
tion and reduce lipid peroxidation [27, 28]. Its mechanism of
action has been proposed by Ito et al. [28]. Eugenol inhibited
iron-mediated lipid peroxidation and copper dependent
LDL oxidation. Though EO contains a lot of methyl eugenol,
there are no supporting data to show its anti-lipidemic and
antioxidative effect.
Conclusions
In summary, EO was able to decrease the serum lipid
profile and AI levels as well as cardiac lipid peroxidation
and significantly enhanced the activity of the cardiac anti-
oxidant enzymes. Our data indicate that EO treatment was
very successful in preventing atherosclerosis and providing
cardiac protection against hypercholesterolemia. The active
ingredient eugenol contained in EO may play an important
role for these therapeutic effects.
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